Skip to Main Content

Author Details

Andrzej Chruscinski
University Health Network
1992
37
19
PMIDPaper TitleJournal TitlePublished Year
36670100Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy.Cell Death Dis2023
37004176Congenic hematopoietic stem cell transplantation promotes survival of heart allografts in murine models of acute and chronic rejection.Clin Exp Immunol2023
34049362Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study.Transplantation2022
35362478Tankyrase represses autoinflammation through the attenuation of TLR2 signaling.J Clin Invest2022
35020854Evaluation of a gene expression biomarker to identify operationally tolerant liver transplant recipients: the LITMUS trial.Clin Exp Immunol2022
34175923Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individuals.Rheumatology (Oxford)2022
34557585Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection.Transplant Direct2021
33592074Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.PLoS One2021
32900843Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study.J Am Soc Nephrol2020
30630065Increases in Serum Autoantibodies After Left Ventricular Assist Device Implantation.J Card Fail2019
31365766A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice.Am J Transplant2019
29341118Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13.Immunology2018
28487604Overexpression of fibrinogen-like protein 2 protects against T cell-induced colitis.World J Gastroenterol2017
26718313Overexpression of Fibrinogen-Like Protein 2 Promotes Tolerance in a Fully Mismatched Murine Model of Heart Transplantation.Am J Transplant2016
27685156Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies.J Vis Exp2016
26967734Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation.PLoS One2016
24990517The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.Immunology2015
26241231Role of Regulatory T Cells (Treg) and the Treg Effector Molecule Fibrinogen-like Protein 2 in Alloimmunity and Autoimmunity.Rambam Maimonides Med J2015
25232767Markers of inflammation in recipients of continuous-flow left ventricular assist devices.ASAIO J2014
24340001Broad-scale phosphoprotein profiling of beta adrenergic receptor (β-AR) signaling reveals novel phosphorylation and dephosphorylation events.PLoS One2013
22647601Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.Proc Natl Acad Sci U S A2012
22545200Antibody-mediated rejection: an evolving entity in heart transplantation.J Transplant2012
21508803Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies.AIDS2011
19623583Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor.J Cell Biochem2009
18469818Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity.Nat Immunol2008
11544051A genetically engineered cell-based biosensor for functional classification of agents.Biosens Bioelectron2001
11641423Differential distribution of beta-adrenergic receptor subtypes in blood vessels of knockout mice lacking beta(1)- or beta(2)-adrenergic receptors.Mol Pharmacol2001
10878340Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell.J Immunol2000
10899083Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology.Am J Physiol Heart Circ Physiol2000
10595521ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by beta-adrenergic receptors.Neuron1999
10358009Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors.J Biol Chem1999
10358008Targeted disruption of the beta2 adrenergic receptor gene.J Biol Chem1999
9327949The developmental and physiological consequences of disrupting genes encoding beta 1 and beta 2 adrenoceptors.Adv Pharmacol1998
8670422Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c.Science1996
8395893Primary structure of the mouse beta 1-adrenergic receptor gene.Biochim Biophys Acta1993
1353249Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.Mol Pharmacol1992
1354956Cloning and expression of the mouse homolog of the human alpha 2-C2 adrenergic receptor.Biochem Biophys Res Commun1992
  • 1 - 37 of 37

Recommended Authors

Boston Children's Hospital
Career Start Year 2009
Number of shared co-authors 0
Toronto General Research Institute, University Health Network
Career Start Year 2007
Number of shared co-authors 6
Yale University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Wyss Institute for Biologically Inspired Engineering
Career Start Year 2006
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW
Career Start Year 2000
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1998
Number of shared co-authors 0
Yale Cardiovascular Research Center, Yale University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
University of California
Career Start Year 1996
Number of shared co-authors 0
University of Virginia School of Medicine.
Career Start Year 1995
Number of shared co-authors 0
Ulm University
Career Start Year 1995
Number of shared co-authors 0
Hasso Plattner Institute for Digital Health at Mount Sinai
Career Start Year 1992
Number of shared co-authors 0
Institute for Precision Cardiovascular Medicine
Career Start Year 1992
Number of shared co-authors 0
Inc. Research Triangle Park
Career Start Year 1987
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 1987
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
Clinical Trials Group
Career Start Year 1986
Number of shared co-authors 0
Odense University Hospital
Career Start Year 1985
Number of shared co-authors 0
University of Southern California Keck School of Medicine
Career Start Year 1985
Number of shared co-authors 0
University of Cambridge Clinical School, LIFNanoRx Ltd
Career Start Year 1984
Number of shared co-authors 0
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 1982
Number of shared co-authors 0
Translational and Clinical Research Institute, Newcastle University
Career Start Year 1981
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 1980
Number of shared co-authors 1
Cincinnati Children's Hospital Medical Center
Career Start Year 1975
Number of shared co-authors 1
National Academy of Medicine.
Career Start Year 1974
Number of shared co-authors 1
Harvard Medical School
Career Start Year 1973
Number of shared co-authors 0
Monash University
Career Start Year 1958
Number of shared co-authors 0

Collaborators

Toronto General Hospital, University of Toronto
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
HudsonAlpha Institute for Biotechnology, Stanford University
Co-authored papers 3
Schroeder Arthritis Institute
Co-authored papers 2
Schroeder Arthritis Institute
Co-authored papers 2
University of Toronto
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Mount Sinai Health System and University Health Network
Co-authored papers 1
University Health Network, University of Toronto
Co-authored papers 1
University Health Network, University Health Network and University of Toronto
Co-authored papers 1
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Co-authored papers 1
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Universite de Montreal
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Princess Margaret Cancer Centre, University Ave
Co-authored papers 1
Co-authored papers 1
Toronto Western Hospital, University of Toronto
Co-authored papers 1
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Co-authored papers 1
Co-authored papers 1
Mount Sinai Hospital.
Co-authored papers 1
University of Toronto
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Co-authored papers 1
Toronto Western Hospital and Schroeder Arthritis Institute, University Health Network
Co-authored papers 1
Hospital for Sick Children
Co-authored papers 1
Hospital for Sick Children, University of Toronto
Co-authored papers 1
Research Institute, The Hospital for Sick Children
Co-authored papers 1